Recombinant Measles Virus Vaccine Expressing the Nipah Virus Glycoprotein Protects against Lethal Nipah Virus Challenge

• Misako Yoneda ,

  * E-mail: yone@ims.u-tokyo.ac.jp (MY); ckai@ims.u-tokyo.ac.jp (CK)

  Affiliation Laboratory Animal Research Center, Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan

  ⨯
• Marie-Claude Georges-Courbot,

  Affiliation Institut National de la Sante et de la Recherche Médicale, Laboratory P4 INSERM Jean Mérieux, Lyon, France

  ⨯
• Fusako Ikeda,

  Affiliation Laboratory Animal Research Center, Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan

  ⨯
• Miho Ishii,

  Affiliation Laboratory Animal Research Center, Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan

  ⨯
• Noriyo Nagata,

  Affiliation National Institute of Infectious Diseases, Department of Pathology Tokyo, Japan

  ⨯
• Frederic Jacquot,

  Affiliation Institut National de la Sante et de la Recherche Médicale, Laboratory P4 INSERM Jean Mérieux, Lyon, France

  ⨯
• Hervé Raoul,

  Affiliation Institut National de la Sante et de la Recherche Médicale, Laboratory P4 INSERM Jean Mérieux, Lyon, France

  ⨯
• Hiroki Sato,

  Affiliation Laboratory Animal Research Center, Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan

  ⨯
• Chieko Kai

  * E-mail: yone@ims.u-tokyo.ac.jp (MY); ckai@ims.u-tokyo.ac.jp (CK)

  Affiliations Laboratory Animal Research Center, Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan, International Research Center for Infectious Diseases, Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan

  ⨯